Sacituzumab Govitecan Granted Accelerated Approval for Advanced Urothelial Cancer
April 14th 2021Sacituzumab govitecan (Trodelvy) approved for patients with locally advanced or metastatic urothelial cancer who previously received a platinum-containing chemotherapy and either a PD-1 or PD-L1 inhibitor.
Read More
HOPA 2021: New Therapies on the Horizon for Advanced NSCLC
April 13th 2021A session at the Hematology/Oncology Pharmacy Association Virtual Annual Conference provided an overview of how treatment options are changing with potential new therapies in development for patients with non-small cell lung cancer.
Read More
Johnson & Johnson, AstraZeneca COVID-19 Vaccines Share Concerns About Rare Blood Clots
April 13th 2021As the FDA and CDC have paused use of the Johnson & Johnson COVID-19 vaccine in the United States, research is ongoing to understand whether cerebral venous sinus thrombosis (CVST) is directly linked to the vaccine.
Watch
Three Major Studies Alter the Practice of Treating Gastroesophageal Carcinomas
April 12th 2021A presentation at the Community Oncology Alliance 2021 Virtual Conference focused on the latest developments in gastrointestinal oncology and how the field of gastroesophageal cancer is responding to 3 major, practice-changing trials.
Read More
How Pharmacists Can Protect Patients from Outdated COVID-19 Treatment
April 12th 2021The pharmacist is the last barrier between a patient and a drug, which is why it's critical for pharmacists to check for allergies, potential drug interactions, patient understanding of how to use the drug, and whether the prescription is appropriate for the diagnosis.
Read More
Artificial Intelligence Identifies Novel Multiple Sclerosis Subtypes
April 12th 2021A new study published in Nature Communications used artificial intelligence (AI) to identify 3 new multiple sclerosis (MS) subtypes, which may help identify which individuals are more likely to have disease progression, according to the authors.
Read More
Choice of Blood Pressure Medications Impacts Long-Term Heart Disease Risk in Patients With HIV
April 12th 2021Among patients with HIV who had not been diagnosed with heart disease at the beginning of the study, the risk of developing heart disease, heart failure, or stroke for the first time was 90% higher among those taking beta-blockers.
Read More
Study: Mild Diet, Exercise Improves Survival for Young People With Leukemia
April 12th 2021The researchers found that patients who reduced their calorie intake by 10% or more and adopted a moderate exercise program immediately after their diagnosis had, on average, 70% less chance of having lingering leukemia cells after a month of chemotherapy than those not on the diet-and-exercise regimen.
Read More
Gridlock, Middleman Lobbying Cause Pharmacy Benefit Manager Reforms to Fail Again in New York Budget
April 12th 2021Many pharmacies and safety-net providers were preparing for the long-anticipated transition from Medicaid managed care to fee-for-service (FFS)—known as the carve-out—that was set to take effect on May 1, 2021.
Read More
Approaching the Process of Operationalizing Biosimilars in Cancer Care
April 9th 2021The first step toward operationalizing the uptake of biosimilars is having a program-level discussion that not only describes what biosimilars are, but also assesses how they impact the bottom line and could get incorporated into treatment plans.
Read More
Study: Consumption of Processed Meat Linked to Higher Rates of Mortality, Cardiovascular Disease
April 9th 2021The study did not find significant associations between the intake of unprocessed red meat or poultry with either of these conditions, in contrast to prior studies that linked red meat to higher risks of cardiovascular disease.
Read More